Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.75 Issue 1 / 2012
  4. Article
Editorial
Views

Arq. Bras. Oftalmol. 2012; 75 (1):

Total: 1356

Cost-effectiveness comparison between non-penetrating deep sclerectomy and maximum-tolerated medical therapy for glaucoma within the Brazilian National Health System (SUS)

Submission is temporarily unavailable. reCAPTCHA validation has not been configured yet.
This article not yet has been commented, be the first!

PDF English Print
Open Access
Share

How to cite this article:

Comparação de custo-efetividade entre a esclerectomia profunda não penetrante e a terapia clínica máxima tolerada para o glaucoma no Sistema Único de Saúde (SUS). Arq. Bras. Oftalmol. 2012;75(1):.
Export citation